EPO Patents = 1

Trademarks = 1

Forward Citations = 8

Loading Chart...

6 inventors (with patents filed for the assignee):

Mitchell H Finer (4 out of 6 patents)

Luke Evnin (2 out of 3 patents)

Kenneth P Greenberg (2 out of 2 patents)

4. Christophe Quéva (1 out of 2 patents)

5. Edward Kennedy (1 out of 2 patents)

6. Lorena Lerner (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 11612625 - Oncolytic viral vectors and uses thereof (2023-03-28),

2. 11452750 - Oncolytic viral vectors and uses thereof (2022-09-27),

3. 11078280 - Oncolytic viral delivery of therapeutic polypeptides (2021-08-03),

4. 10604574 - Oncolytic viral delivery of therapeutic polypeptides (2020-03-31),

5. 10391132 - Oncolytic viral vectors and uses thereof (2019-08-27),

Oncorus is a biotechnology company focused on developing next-generation viral immunotherapies to combat cancer. The company's innovative platform combines viral vectors with immunotherapies to create more effective treatments for patients. Oncorus is dedicated to advancing the field of oncolytic viruses and improving outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#336 in Cambridge, MA

#2,815 in Massachusetts

#50,245 in US

Cambridge, MA, United States of America

Oncorus, Inc.